Cancer Pain

Radiofrequency ablation successfully treats bone pain

Published in Medical Letter on the CDC and FDA, December 1st, 2002

An international clinical study led by Mayo Clinic in Rochester, Minnesota, showed that radio-frequency (RF) ablation significantly reduces pain and enhances quality of life for patients whose cancer has spread to the bone.

The study provided evidence used by the U.S. Food and Drug Administration (FDA) to approve RF ablation for treatment of pain in cancer patients with two or three painful bone metastatic sites. The announcement of FDA approval was made October 21, 2002.

RF ablation has been used for several years to treat liver and kidney cancer. The Mayo Clinic study shows that RF ablation can be equally effective in killing cancer cells that...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2002-12-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry